Abstract
Understanding and mitigating SARS-CoV-2 transmission hinges on antibody and viral RNA data that inform exposure and shedding, but extensive variation in assays, study group demographics and laboratory protocols across published studies confounds inference of true biological patterns. Our meta-analysis leverages 3214 datapoints from 516 individuals in 21 studies to reveal that seroconversion of both IgG and IgM occurs around 12 days post-symptom onset (range 1-40), with extensive individual variation that is not significantly associated with disease severity. IgG and IgM detection probabilities increase from roughly 10% at symptom onset to 98-100% by day 22, after which IgM wanes while IgG remains reliably detectable. RNA detection probability decreases from roughly 90% to zero by day 30, and is highest in feces and lower respiratory tract samples. Our findings provide a coherent evidence base for interpreting clinical diagnostics, and for the mathematical models and serological surveys that underpin public health policies.
Highlights
Since its emergence in December 2019, the SARS-CoV-2 pandemic has been the subject of intense research assessing all facets of the pathogen and its rapid global spread
In 21 studies reporting the kinetics of anti-SARS-CoV-2 antibodies, we found the use of 8 different antibody assays, 10 different target antigens, and 9 different reported antibody level units
When reporting enzyme-linked immunosorbent assay (ELISA) results in the main text, IgG results are shown for assays targeting the nucleoprotein (NP) antigen (ELISA-NP), and
Summary
Since its emergence in December 2019, the SARS-CoV-2 pandemic has been the subject of intense research assessing all facets of the pathogen and its rapid global spread. At the level of populations, serologic data can provide insights into virus spread by enabling estimation of the overall attack rate, and seroprevalence estimates can elucidate the potential for herd immunity (Stringhini et al, 2020; Bryant et al, 2020). These estimates are essential for developing accurate mathematical models of virus transmission dynamics, which provide the foundation for policies to reopen societies (Krsak et al, 2020; Angulo et al, 2020; Kissler et al, 2020).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.